“…The produced protein by this method is sufficiently supplied throughout clinical study. This method is also employed in the production of therapeutic proteins like anti-human PD-1 antibodies [ 48 ] and anti-botulinum neurotoxins [ 49 ] which are previously developed in our laboratory. Therefore, using agroinfiltration for the production of D54 mAb is more appropriate than stable transformation.…”